A2HC34 Stock Overview
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
AdaptHealth Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.93 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 1 |
| 1 Month Change | -14.63% |
| 3 Month Change | -19.31% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -47.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| A2HC34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 0% | 2.8% | 0.9% |
| 1Y | n/a | 2.9% | 15.2% |
Return vs Industry: Insufficient data to determine how A2HC34 performed against the BR Healthcare industry.
Return vs Market: Insufficient data to determine how A2HC34 performed against the BR Market.
Price Volatility
| A2HC34 volatility | |
|---|---|
| A2HC34 Average Weekly Movement | 9.2% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in BR Market | 9.0% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: A2HC34's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine A2HC34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 10,900 | Richard Barasch | adapthealth.com |
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors.
AdaptHealth Corp. Fundamentals Summary
| A2HC34 fundamental statistics | |
|---|---|
| Market cap | R$4.80b |
| Earnings (TTM) | -R$2.10b |
| Revenue (TTM) | R$15.36b |
0.3x
P/S Ratio-2.3x
P/E RatioIs A2HC34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A2HC34 income statement (TTM) | |
|---|---|
| Revenue | US$3.12b |
| Cost of Revenue | US$2.64b |
| Gross Profit | US$478.31m |
| Other Expenses | US$905.08m |
| Earnings | -US$426.77m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.16 |
| Gross Margin | 15.32% |
| Net Profit Margin | -13.67% |
| Debt/Equity Ratio | 124.5% |
How did A2HC34 perform over the long term?
See historical performance and comparison